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Summary
Recent studies have demonstrated that mature natural killer (NK) cells can be grown from human
triple negative (TN; CD3- ,CD4 - ,CD8-) thymocytes, suggesting that a common NK/T cell
precursor exists within the thymus that can give rise to both NK cells and T cells under appropriate
conditions. In the present study, we have investigated human fetal and postnatal thymus to determine
whether NK cells and their precursors exist within this tissue and whether NK cells can be
distinguished from T cell progenitors. Based on the surface expression of CD56 (an NK
cell-associated antigen) and CD5 (a T cell-associated antigen), three phenotypically distinctive
populations of TN thymocytes were identified. CD56+,CD5 - ; CD56 - ,CD5 - , and CD56`,
C135 + . The CD56+,CD5- population of TN thymocytes, although displaying a low cytolytic
function against NK sensitive tumor cell targets, were similar in antigenic phenotype to fetal
liver NK cells, gave rise to NK cell clones, and were unable to generate T cells in mouse fetal
thymic organ cultures (mFTOC). This population of thymocytes represents a relatively mature
population of lineage-committed NK cells. The CD56- ,CD5 - population of TN thymocytes
were similar to thymic NK cells in antigenic phenotype and NK cell clonogenicpotential. Clones
derived from this population of TN thymocytes acquired CD56 surface expression and NK cell
cytolytic function. CD56 - ,CD5 - TN thymocytes thus contain a novel population of NK
cell-committed precursors. The CD56 - ,CD5 - population of TN thymocytes also contains a
small percentage of CD34+ cells, which demonstrate no in vitro clonogenic potential, but
possess T cell reconstituting capabilities in mFTOC. The majority of TN thymocytes do not
express CD56, but coexpress CD34 and CD5. These CD56- ,CD5+,CD34+ cells demonstrate
no NK or T cell clonogenic potential, but are extremely efficient in repopulating mFTOC and
differentiating into CD3+,CD4+,CD8+ T cells. The results of this investigation have identified
NK cells and NK cell precursors in the human thymus and have shown that these cell types
are unable to differentiate along the T cell lineage pathway. Thus, while a common NK/T cell
progenitor likely exists, once committed to the NK cell lineage these cells no longer have the
capacity to develop along the T cell developmental pathway.
H uman T cell development involves a series of intrathymic
events during which fetal liverand/or bone marrow-de-
rived progenitor cell populations migrate to the thymic an-
lage, and undergo a poorly understoodprocess ofdifferentia-
tion (1-4). It is generally accepted that the earliest T cell
precursors in the thymus lack the expression of CD3, CD4,
and CD8 and are thus referred to as triple negative (TN)l
thymocytes (5-10). It has recently been demonstrated that
the majority of these humanTN thymocytes express the pro-
genitor cell-associated antigen CD34 (11) and are capable of
t Abbreviations used in this paper: mFTOC, mouse fetal thymic organ
culture; TN, triple negative.
developing into mature T cells in human thymic organ cul-
tures (12). CD34+ fetal liver and bone marrow progenitors
have also been shown to reconstitute human fetal thymic im-
plants in the SCID/Hu mice (13).
NK cell differentiation, however, is at present poorly un-
derstood, primarily due to the lack of a specific organ for
maturationand a defined antigen receptor on these cells. The
differentiation and development of NK cells and their rela-
tionship to the T cell lineage remains controversial. Although
it has been described that NK cells are present in both the
human (14) and the mouse thymus (15), it is generally be-
lieved that the development of NK cells is independent of
the thymic microenvironment, particularly since NK cells
develop normally in athymic mice (16), and differentiated NK
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appearance of the thymic anlage (17). Nevertheless, different
subsets of human T and NK cells share lytic activity (18)
and express many membrane antigens in common, including
CD2, CD7, CD8, CD16, and CD56 (19). It has also been
reported that NK cellscan express cytoplasmic CD3 proteins
(19, 20) and nonfunctional transcripts for the TCR chains
(21). Despite these similarities, NK cells do not express the
T cell-associated antigen CD5 or rearrange the TCR genes
(17, 22).
Due to these phenotypic and functional similarities, it has
been proposed that NK cells are related to the T cell lineage
and may indeed share a common T/NK cell-committed pro-
genitor. This hypothesis has been supported by the ability
of human total thymocytes (23-26) and TN thymocytes to
generate NK and T cells under appropriate in vitro condi-
tions (27, 28) and by the ability of murine FcyRII/III+ TN
thymocytes to generate NK cells and T cells in vivo (29).
The identification of a common T/NK cell progenitor re-
mains elusive, since previous studies have employed hetero-
geneous populations of thymocytes that may contain several
distinctive lineage-committed progenitor populations.
In the present study, we have attempted to clarify the rela-
tionship between NK cells and T cells in the thymus by pheno-
typically dissecting human TN thymocytes and determining
the capacity of various subpopulations to generate NK cells
in vitro and T cells in thymic organ cultures. Our results
show that CD56 +,CD5 - ,CD34- and CD56- ,CD5 - ,CD34-
TN thymocytes include NK and NK cell-committed pre-
cursors, respectively, incapable of generating T cells in mouse
fetal thymic organ cultures (mFTOC). CD34+ TN thymo-
cytes, on the other hand, are incapable ofgenerating NK cells
using in vitro cloning conditions, while efficiently differen-
tiating to T cells in mFTOC.
Materials and Methods
Cell Preparations.
￿
Fetal thymic and liver tissue were obtained
from elective therapeutic abortions. Gestation age was determined
by crown-ramp length and ranged from 13 to 24 wk. Newborn
thymic tissue was obtained from normal pediatric subjects under-
going median stemotoray and corrective cardiovascular surgery.
Mononuclear cells were prepared from fetal liver by standard Ficoll-
Hypaque procedures, followed by magnetic bead depletion of
erythroblasts (glycophorin A positive cells), as previouslydescribed
(17). Thymocyte cell suspensions were prepared, and separationof
different thymic populations was performed by a combination of
magnetic bead depletion and cell sorting, as previously described
(11). Newborn and fetal thymic tissue were used interchangeably
in this study, since similar results were obtained in all experiments
regardless of the maturational stage of the thymic tissue.
mAlx
￿
mAbs against the following antigens were used: CDIa
(T6; Coulter Corp., Hialeah, FL); CD2 (Leu 5b); CD3 (Leu 4);
CD4 (Leu3a+b, L77); CD5 (Leu 1, UCHT2; PharMingen, San
Diego, CA); CD7 (Leu 9); CD8 (Leu 2a); CD10 (Calla); CD11a
(1,7); CD11b (Leu 15); CD11c (Leu-M5); CD13 (Leu-M7); CD14
(Leu-M3); CD16 (Leu 11a); CD18 (1,130); CD19 (Leu 12); CD20
(heu-16); CD28 (1,293); CD33 (Leu-M9); CD34 (HPCA-2); CD38
(Leu 17); CD45 (FILE, H130, PharMingen); CD45RA (Leu 18);
CD56 (Leu 19 and 1,185); glycophorin A (10F7Mn; American Tissue
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Culture Center, Rockville, MD); and mouse CD45 (30F11.1, Phar-
Mingen). mAbs were generously provided by Becton Dickinson
Immunocytometry System (San Jose, CA), unless otherwise indi-
cated. Fluorochrome conjugated mouse Ig isotype-specific controls
were from Becton Dickinson Immunocytometry System and Phar-
Mingen. Cy-ChromeTM conjugated streptavidin was purchased
from PharMingen.
Immunofluorescence, Flow Cytometry, and Cell Sorting.
￿
Methods
ofimmunofluorescence staining and cell sorting have been described
previously (17, 30). Enrichmentofselected thymic populations was
performed by incubation with specific mAb followed by magnetic
bead depletion (Dynal Inc., Oslo, Norway) as previouslydescribed
(11). This procedure was repeated two or threetimes until the pu-
rity ofthe cells, monitored by staining with FITC goat anti-mouse
Ig (Caltag Labs., So. San Francisco, CA) was >90%. Three-color
immunofluorescence was performed with PE, FITC, and Cy-
chromeTM fluorochrome-conjugated mAbs, followed by flow cyto-
metric analysis. A gate was set on each subpopulation according
to the expression of CD56 and CD5 and the percentage of cells
bearing the third differentiation Ag was determined. Appropriate
fluorochrome-conjugated isotype-matched control Igs were used
in all experiments. Samples were analyzed using a FACScan® (Becton
Dickinson Immunocytometry System). In some experiments, bead
depletion was performed with FITC-conjugated mAbs to ensure
the purity of the cell subpopulations. Thus, any cell not removed
by magnetic bead depletion would be subsequently detected and
excluded by flow cytometry.
For cell sorting, thymocytes were depleted of CD4+, CD8+,
and glycoprotein A+ cells by two rounds of magnetic bead treat-
ment. Three-color cell sorting was performed by excluding FITC
positive cells. FITC-conjugated anti-CD3,-CD4,-CD8,-CD14,
and -CD19 mAbs were used in cell sorting experiments to prepare
TN thymocytes.
Cloning ofTN Thymic Populations.
￿
After magnetic bead deple-
tion of CD4+ and CD8` cells, thymocytes were stained with
FITC-conjugated anti-CD3, -CD4, -CD8, -CD14, and -CD19,
PE-conjugated anti-CD56 mAb and Cy-ChromeTM-conjugated
anti-CD5 mAb. Thymocytes from each population were cloned
at one cell per well in 96-well plates (Costar Corp., Cambridge,
MA) using a single cell deposition system ofthe FACStar Plus® flow
cytometer. Clones were established using culture conditions previ-
ously described (31) with minor modifications. Briefly, cells were
seeded in culture plates containing 5 x 104 irradiated peripheral
blood mononuclear cells (PBMC) and 5 x 103 irradiated JY (EBV
transformed B cells) as feeder cells and 0.1 ug/ml PHA (Burroughs
Wellcome Co., Research Triangle, NC) in 200 p.l of Yssel's media
supplemented with 10% FCS (1R Scientific, Woodland, CA) and
2% human AB serum(Pel-Freez, Brown Deer, WI). 7 d later IIr2
(DNAX Research Institute) was added (100 U/ml). Clones were
analyzed for the expression of CD56, CD3, and CD16 after 2-3
wk of culture. The antigenic phenotype and lytic activity was de-
termined weekly. Clones were fed every 3 d with 11,2 and restimu-
lated every week with irradiated feeder cells.
Cell-mediated Cytotoxicity.
￿
Cytotoxic activity was measured in
a standard 4-h 5'Cr radioisotope release assay (32) using NK-
sensitive K562 erythroleukemia cells as targets.
Thymic Organ Culture.
￿
For the in vitro T cell development of
human TN thymocytes we used the mouse fetal thymic organ cul-
ture system previously described by Fisher et al. (33), with minor
modifications. Briefly, thymuses were removed from embryos of
BALB/c mice on day 15 of gestation and treated with 1.35 mM
2'-deoxyguanosine (dGu) (Sigma Chemical Co., St. Louis, MO)
for 5 d. Human CD45+ thymic TN populations were sorted to>95% purity. The thymic lobes were cocultured with sorted human
thymicTN population in Iscove'sModifiedDulbecoo Media(IMDM).
(GIBCO Laboratories, Grand Island, NY), containing2% human
AB serum, as previously described (33, 34) . The mice lobes with
the human cells were placed on nucleopore filters (0.8 lim, Costar
Corp.) over gelfoam rafts (Upjohn Company, Kalamazoo, MI) and
cultured for 15 d. At the end of the incubation periods, thymic
lobes were homogenized in PBS and analyzed . Three-color im-
munofluorescence was performed by incubating the cells with Cy-
ChromerM-conjugated anti-human CD45 mAb, PE anti-CD8,
FITC anti-CD3, and FITC anti-CD4 . In some experiments anti-
mouse CD45 mAb was used to detect residual mouse leukocytes.
Results
NK Cells Are Present in the Human Thymus and Do Not
Differentiate to T Cells. Thymocytes from fetal (13-23 wk
of gestation age) and neonatal thymuses were examined for
the expression of the NK cell-associated antigen CD56 and
the T cell-associated antigenCD5 . CD5 is expressed during
all differentiation stages of human T cell development, in-
cluding Thmocytes and circulating T cells (11, 35) and has
never been observed on fetal or adult NK cells (17) . Thus,
analyzing the expression ofCD56 and CD5 on TN thymo-
cytes allows for the dissociation of NK cells (CD56+,
CD5 - ) from T cells (CD56 -,CD5+) . A minor population
ofCD56+,CD5 - cells (<0.05%) was detected in neonatal
thymus and fetal thymus after 20 wk of gestation (Fig. 1
B) . At earlier developmental stages (13-20wk of gestation),
the CD56+,CD5 - population comprised a greater per-
centage (0.4-0.1%) of CD45+ thymocytes . The CD56+,
CD5 - Thmocytes were primarily contained within the
CD3 - ,CD4-,CD8 - population. Therefore, to enrich for
CD56+,CD5- cells, Thmocytes were depleted of T cells
(CD3+,4+,8+), B cells (CD19+), and monocytes (CD14+) .
The resulting cell population, which will subsequently be
referred to as TN thymocytes, comprised 5-10% of total
Thmocytes, and contained 3-15% CD56+,CD5- cells (Fig .
1 C) .
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Figure 1 .
￿
CD56 and CD5 expression on total and TN thymocytes.
Human fetal thymocytes and TN thymocytes from an 18-wk gestation
fetus were prepared as described in Materials and Methods and analyzed
by three-color flow cytometry for the expression ofCD56, CD5, and CD45
antigens. Two-color contour maps of CD45+-gated cells were divided into
quadrants based on >95% of the cells residing in the lower left quadrant
after staining with isotype control mAbs (A) . Of total CD45+ thymo-
cytes, CD56+CD5- cells comprised <0.05% of the total thymocytes (B).
Three cell populations were observed inTN thymocytes preparations (C);
CD56+,CD5 - (range 3-15%) ; CD56 - ,CD5- (range 1-10%) ; and
C]356- ,CD5+ (range 75-96%) .
Figure 2 .
￿
Comparative phenotype of fetal liverNK cells and CD56',
CD5 - TN thymocytes . Fetal liver mononuclear cells (open ban) and TN
thymocytes (black ban) wereisolated from 15-20-wk-gestation-age fetuses
as described in Materials and Methods and were stained by three-color
immunofluorescence using mAbs against CD56, CD5, and a panel ofleu-
kocyte antigens. By setting a gate on CD56*,CD5 - cells, it was possible
to determine the proportion ofcells within each subset that expressed the
third differentiation Ag. Thepercentages shown are averagesbased on anal-
ysis of at least three tissue samples.
A comparison ofCD56+, CD5' TN Thmocytes to fetal
liver NK cells revealed remarkable similarities. Analysis of
cell surface antigen expression showed that both CD56+,
CD5 - TN Thmocytes and fetal liver NK cells expressed
CD7, CD11a, CD18, and high surface density CD38, CD45,
and CD45RA antigens (Fig . 2) . CD2, CD11b, CD11c, and
CD16 antigens were expressed on variable percentages ofboth
CD56+,CD5 - TN thymocytes and fetal liver NK cells. In
addition, thymic CD56+,CD5 - TN cells and fetal liver NK
cells did not express the thymic T cell-associated antigenCD1a;
theB cell-associated antigenCD20; the monocytic/myeloid-
associated antigens, CD13, andCD33 ; or the progenitor cell-
associated antigens CD34 and CD10. Unlike fetal liver NK
cells, however, the majority of CD56+,CD5 - TN thymo-
cytes did not express the T cell-associated antigen, CD28
(Fig. 2) .
To determine the cytolytic capabilities of fetal thymic
CD56+,CD5 - TN cells these cells were sorted to greater
than 98% purity and assayed for cytolytic activity against
the NK sensitive tumor cell target K562 (Fig. 3) . CD56+,
CD5 - TN Thmocytes demonstrated measurable levels of
NK cell-mediated cytotoxicity, albeit lower than that medi-
ated by freshly isolated fetal liver NK cells .
CD56+,CD5 - TN thymocytes were cloned from fetal
and neonatal thymus using cellular cloning techniques that
have been previously shown to be optimal for expansion of
NK and T cells (17, 31) . The cloning frequency of CD56+,
CD5 - TN Thmocytes ranged from 1/25 to 1/100 and weret0
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￿
Cytotoxic activity offreshly isolatedTN thymic populations .
CD56+,CD5 - , CD56- ,CD5 - , and CD56 - ,CD5+ TN thymocytes were
sorted to >95% purity and assayed for cytotoxic activity against theNK
cell-sensitive tumor cell target, K562, in a 4-h s3Cr release assay. Effector
to target ratio = 25 :1. Representative results from three experiments are
presented . Fresh fetal liverNKcells were usedas a control for comparison .
comparable to the cloning frequencies observed for fetal liver
NK cells . In most experiments, however, neonatal thymic
CD56+,CD5 - TN cells displayed higher cloning frequen-
cies than those observed for fetal CD56+,CD5 - TN thymo-
cytes . Over 200 fetal and neonatal thymic NK clones were
established from more than 10 thymic tissue samples and ana-
lyzed for cytolytic function and cell surface antigenic pheno-
type. All clones established from thymic CD56+,CD5- TN
thymocytes maintained a typical NK cell antigenic pheno-
type (CD56+,mCD3 - ) (Fig . 4) . 40-80% of these NK
clones expressed the low affinity IgG Fc-receptor, CD16 (not
shown) . These clones also demonstrated potent cytolytic ac-
tivity against the NK-sensitive tumor target, K562 (Fig . 4) .
Phenotypic, functional, and cloning experiments clearly
indicated that thymic CD56+,CD5 - TN cells were com-
mitted to the NK cell lineage, however, in order to deter-
mine if these cells possessed anyT cell differentiation capac-
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Figure 4.
￿
Phenotypic and functional activity of clones derived from
CD56+,CD5 - TN thymocytes . Clones were established as described in
Materials and Methods from CD56+,CD5 - TN thymocytes . The expres-
sion of CD56 and surface CD3 (mCD3) was analyzed after 1 mo in cul-
ture (A, representative clone) . All the clones established from this popula-
tion were CD56+,mCD3 - . Clones were assayed for cytotoxic activity
against K562 in 4-h S'Cr release assay (ET = 5 :1) . The cytolytic func-
tion of six representative clones is displayed (B) .
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ity, CD56+,CD5 - TN thymocytes were introduced into
mFTOC, a system that has previously been shown to sup-
porthumanT cell differentiation and maturation (33) . Freshly
sorted thymic CD56+,CD5 - and CD56 - ,CD5+ TN thy-
mocytes were introduced into mouse thymic lobes and cocul-
tured for 15 d . After culture, the number ofviable cells was
determined together with the expression of human CD4,
CD8, and CD45 surface antigens . Large numbers of viable
cells were recovered from lobes seeded with CD56- ,CD5+,
TN thymocytes (16-30-fold cell expansion) . Most ofthe he-
matopoietic cells isolated from the mouse thymic lobes were
of human origin (>90% hCD45+) . 50% of them were
CD3+, and 60-90% coexpressed CD4 and CD8 antigens
(Fig . 5, A and B) . In contrast, thymic CD56+,CD5 - TN
thymocytes failed to reconstitute these organs (Fig . 5, C and
D) and the few cells that were recovered were stained with
anti-mouse CD45 mAb .
The extremely effective reconstitution capacity of the
CD56 - ,CD5+ TN thymocyte population to differentiate
into CD4+,CD8+ T cells in mFTOC substantiates the hy-
pothesis that these cells represent the major population of
T cell-committed progenitors in the thymus . Previous reports
Figure 5 .
￿
Phenotype of human thymocytes recovered from mFTOC.
Three-color sorted CD56*,CD5- and CD56 - ,CD5+ TN cells were
cocultured with mouse fetal thymic lobes. 103 cells were seeded per lobe.
After 15 d in culture the recovered cells (10 lobes) were subjected to three-
color immunofluorescence analysis for the expression of human antigens
(Cy-ChromeTM conjugated anti-CD45, PE anti-CD8, and FITC anti-
CD4) . A and B show the surface antigen expression of recovered cells
from thymic lobes seeded with CD56- ,CD5+ TN thymocytes. More
than 90% are human CD45+ (hCD45) (A) . 70% of the hCD45+ cells
coexpressed human CD4 and CD8 (B) . C and D show the phenotype
of cells recovered from thymic lobes seeded with the CD56+,CD5 - TN
population . Less than 2% were CD45+ . The hCD45 - cells expressed the
mouse CD45 antigen, recognized by anti-mouse T200mAb (not shown) .have shown that CD34+ cells from human fetal liver, bone
marrow, and thymus contain T cell progenitors capable of
reconstituting thymic organ cultures (12, 13) . Consistent with
these studies, the majority of CD56- ,CD5+ TN thymo-
cytes coexpressed CD34, CD1, and CD28 antigens (Fig . 6)
and demonstrated no in vitro clonogenic potential . These
results clearly show that the CD56+,CD5 - and CD56- ,
CD5+ TN thymocyte populations are distinct, suggesting
that they represent independent NK and T cell-committed
thymocyte populations, respectively .
CD56 -,CD5- TN Thymocytes Include Distinct Precutsorsfor
T andNK Cell Lineages. In addition to the CD56+,CD5 `
cells, a significant percentage of TN thymocytes expressed
neither CD56 nor CD5 (Fig . 1 C) . These CD56-,CD5'
TN thymocytes were compared by multiparameter flow
cytometry to the CD56+,CD5 - and CD56 -,CD5+ TN
populations . As summarized in Fig. 6, CD56 - ,CD5- TN
thymocytes expressedCD45, indicating hematopoietic origin,
and displayed an antigenic profile very similar to the CD56+,
CD5' TN thymocytes, except for the expression ofCD16.
CD16 was not expressed on a significant percentage of
CD56- , CD5 - TN thymocytes (<1%) . Similar to
CD56+,CD5' TN thymocytes, CD1, CD28, and CD34
antigens were not expressed on the majority of
CD56-,CD5- TN thymocytes (Fig . 6) . Interestingly, a very
small percentage of CD34+ cells (1-10%) was consistently
detected within the CD56- , CD5 ` TN population (Fig. 7).
Unlike the majority of CD56-,CD5 - cells, these CD34+
cells coexpressed CD28 and low surface density CD45 (data
Figure 6 .
￿
Comparative phenotype ofCD56+CD5- , CD56- CD5 - ,
and CD56 -CD5+ TN thymocytes.TN thymocytes were prepared as de-
scribed in Materials and Methods and stained with mAbs against CD56,
CD5, and a selected panel of leukocyte antigens . CD56*,CD5- (black
ban), CD56-CD5 - (dashed bars), and CD56 - ,CD5+ (open ban) TN
populations wereanalyzed for the various antigens by sequentially setting
a gate on each population during analysis . The percentages shown are the
results ofa single representative experiment . Similar results were obtained
from three thymuses . Asterisk indicates that the antigen is expressed at
a significantly lower surface density in CD56- ,CD5+ TN cells compared
with the other thymic cell subsets (as described in Results) .
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Figure 7 .
￿
Expression ofCD34 onTN thymic populations . After mag-
netic bead depletion of CD4+,CD8+ thymocytes, three-color immuno-
fluorescence was performed on CD56+,CD5 - , CD56- ,CD5 - , and
CD56- ,CD5* TN population to determine the expression of CD34.
CD34+ cells comprise <1% of CD56+ CD5 - TN, 6% of CD56- ,
CD5 - TN, and 96% ofCD56 - ,CD5+ TN cells. Data from a represen-
tative experiment are shown . Histograms ofCD34 stained cells (open) are
superimposed over histograms ofisotype Ig control stained cells (black) .
not shown) . Similar to CD56+,CD5 - TN thymocytes,
freshly sorted CD56 - , CD5 - TN thymocytes demonstrated
poor cytolytic activity against the NK-sensitive tumor target,
K562 (Fig. 3) .
The majority of surface antigens expressed on CD56- ,
CD5 - TN thymocytes suggested that this population may
contain NK cell-committed precursors. To determine theNK
cell differentiation capacity of this thymocyte population,
CD56 - ,CD5 - TN cells were cloned using culture condi-
tions optimized for the growth ofNK andT cells . The cloning
efficiencies of both the CD56+,CD5 - and the CD56',
CD5 - TN thymocyte subsets were similar, ranging from
1/25 to 1/100 . The majority of clones (N70%) established
from the CD56-,CD5 - TN population displayed typical
NK cell antigenic phenotype (CD56+,mCD3 -) and showed
strong cytolytic activity (Fig . 8, A and B) . Interestingly,
-30% of the clones established from the CD56- , CD5 -
TN population expressed variable levels ofCD56 (Fig. 8, C
and E) . The majority of these clones expressed low surface
density CD56 (Fig . 8 C) and demonstrated lower cytolytic
activity than the typical high surface density expressing clones
(Fig . 8 D) . Since these clones were established from CD56 -
cells, the intermediate expression ofCD56 on a proportion
of cells suggested that these clones may be in the process of
in vitro maturation .
A small percentage of the clones established from the
CD56- ,CD5 - TN thymocyte population expressed little if
any surface CD56 at the time of initial analysis (Fig . 8 E) .
These particular clones, likewise, showed no apparent cyto-
lytic activity against NK-sensitive tumor targets (Fig. 8 F) .
Despite the lack ofCD56 expression and NK cell cytolytic
activity, these clones displayed a typical NK cell phenotype
with respect to a large panel of cell surface antigens (data
not shown) . In order to determine if these clones were capable
ofNK cell maturation, several CD56- clones were sequen-
tially monitored for the expression ofCD56 and the acquisi-
tion of NK cytolytic function . As demonstrated in Fig.Figure 8.
￿
Phenotype and lytic activity of clones derived from CD56- ,
CD5 - TN thymocytes . Clones were established as described in Materials
and Methods from CD56- ,CD5- TN thymocytes . Expression of CD56
and mCD3 was analyzed after 1 mo in culture, together with the lytic
activity against theNK cell-sensitive tumor cell target, K562 . Three general
types of clones were observed with varied CD56 expression (A, C, E).
The approximate percentage of clones with the indicated phenotype in
15 different cloning experiments was : CD56' bright, 50-100% ; CD56'
dim, 0-50% ; and CD56 - , 0-5% . Cells stained with isotype Ig controls
were negative (>95% in the lower left quadrant, not shown) .
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Figure 9.
￿
In vitro maturation ofCD56- clones. CD56 -CD3- clones
derived from the CD56 - CD5 - TN thymocytes were maintained in
cloning culture conditions for at least 12 wk. At 4-wk intervals, the ex-
pression ofCD56 (top histograms) together with the lytic activity against
K562 (bottom bar histogram) was monitored . One representative clone is
displayed in this figure. Cytotoxicity was assayed against K562 at an ET
= 5 :1 . The solid bars represent lytic activity of a typical CD56+ bright
NK cell clone derived from the same thymic population . In the toppanel,
histogram ofanti-CD56 stained cells were superimposed over histograms
of Ig control stained cells .
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9, many CD56- clones gradually acquired expression of
CD56. The acquisition ofCD56 was closely correlated with
the apparent increase in NK cell cytolytic activity. Very few
of the CD56 - clones remained CD56 - after extensive cul-
turing over several months (4 out of 200) . Interestingly, these
stable CD56 - clones demonstrated extremely high prolifer-
ation rates and no detectable cytolytic activity. Whether these
CD56- clones are related to the NK cell lineage is at present
unknown; however, they may represent stable NK cell pre-
cursor clones incapable of in vitro maturation .
Although the CD56 -,CD5 - TN thymocyte population
contains NK cell precursors capable of in vitro maturation,
CD56-CD5 - TN cells may also be capable of T cell
differentiation in the thymic microenvironment . Using
mFTOC, sorted CD56 -,CD5 - , and CD56-,CD5+ TN
thymocyte populations were cocultured with mouse thymic
lobes and analyzed 15 d later . Surprisingly, both thymocyte
populations were capable ofreconstituting thymic organ cul-
tures, although the number of human CD45 + cells recov-
ered from each lobe was 5-10-fold greater in lobes seeded
with the CD56 -,CD5+ TN thymocyte population (Fig .
10) . Since previous studies have shown that CD34+ TN
Figure 10 .
￿
mFTOC reconstitution with CD56- ,CD5 - , TN thymo-
cytes. 14 3 sorted CD56- ,CD5+ TN cells (A and B), CD56- ,CD5 - TN
cells (C and D) and CD56- ,CD5 - TN thymocytes depleted of CD34+
cells (E and F), were cocultured with mouse fetal thymic lobes and subse-
quently stained for the indicated antigens (see Fig. 5, legend) . The per-
centage ofhuman cells was determined by the expression ofbCD45 (70%
hCD45+ cells in A ; 74% in C ; <2% in E) . CD4 and CD8 expression
was displayed for the gated hCD45+ cells. >95% cells stained with con-
trol Ig were in the lower left quadrant of B, D, and F (not shown).thymocytesare primarily responsible for reconstituting thymic
organ cultures (12), we hypothesized that the small percentage
of CD34+ cells within the CD56- ,CD5 - , TN population
(Fig. 7) were responsible for the T cell reconstitution capacity
of this TN population. To test this hypothesis, reconstitu-
tion experiments were performed with sorted CD56 - ,
CD5 - TN thymorytes that were depleted of CD34+ cells.
As predicted, CD34 depleted CD56- ,CD5 - TN thymo-
cytes were no longer capable of reconstituting mFTOC (Fig.
10, E and F). However, the CD34 - , CD56- , CD5 - TN
thymocyte population maintainedin vitro NK cell clonogenic
capabilities. These results strongly support the contention
that the majority of the CD56- ,CD5 - TN thymorytes are
NK cell precursors incapable of T cell differentiation, while
the ability of T cell reconstitution of mFTOC is restricted
to CD34+ TN thymorytes. The CD34+,CD56- ,CD5 - TN
cells, although capable of T cell development in mFTOC,
showed no in vitro clonogenicpotential usingculture condi-
tions optimized for growth of NK cells and mature T cells.
Discussion
In the present report, we have attempted to clarify the rela-
tionship between NK cells and T cells in the thymus by pheno-
typically dissecting human TN thymocytes on the basis of
CD56, CD5, and CD34 surface antigen expression and de-
termining the capacity ofvarious subpopulations to generate
NK cells in clonogenic culture conditions and T cells in thymic
organ cultures. The CD5 antigen, although not restricted
to the T cell lineage, was employed in our studies to identify
thymorytes committed to the T cell lineage, since this an-
tigen is not expressed on fetal or adult NK cells. By contrast
most other T cell markers are shared between T and NK
cells. For example, although not on thymic NK cells, CD28
is constitutively expressed on NK cells from fetal liver. In
the thymus, both CD5 and CD28 antigens, however, are
prominently expressed on CD34+ TN thymocytes capable
of reconstituting thymic organ cultures (11, 12). CD56+,
CD5- TN thymocytes were present in all thymuses ana-
lyzed and comprised 3-15% of TN thymocytes. Phenotypi-
cally, the CD56+,CD5 - TN thymocytes were very similar
to the fetal NK cells, including the expression of CD7 and
variable expression of CD16. The CD16 antigen was not ob-
served on a significant percentage of any other fetal or neo-
natal thymic population. Although thymic CD56+,CD5-
TN cells showed low levels of resting cytolytic activity, they
demonstrated an NK cell clonogenic capability similar to that
observed for fetal liver NK cells. Clones derived from the
CD56+,CD5- TN thymorytes expressed typical NK cell
function and antigenic phenotype, including high surface den-
sity CD56, variable expression ofCD16, and no surface CD3.
As was observed in fetal liver-derived NK cell clones (17),
a substantial proportion ofthese thymic NK clones expressed
cytoplasmic CD3 proteins (data not shown), clearly indicating
that detection of cytoplasmic CD3 proteins is no longer an
unambiguous marker for the T cell lineage even in the thymus
(17, 20). The CD56+,CD5 - TN thymocyte population,
likewise, was unable to reconstitute mFTOC and thus con-
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tained no T cell lineage-committed progenitors. The charac-
teristics of the CD56+,CD5- TN thymocyte population are
consistent with the interpretation that these cells represent
a relatively mature population of NK cells. In contrast to
our findings, it was recently reported that a significant per-
centage of human CD3 - ,CD4 - thymocytes coexpressed the
CD16 and CD1 antigens without expressing the CD56 an-
tigen and that these cells could give rise to NK cell clones
(14). We have been unable to verify these observations using
TN thymocyte populations. In our preparations, CD16 was
expressed primarily on NK cell-committed CD56+ cells.
Since the CD56 antigen is expressed at relatively low surface
density on fetal NK cells, these investigators probably failed
to detect CD56 expression due to inadequately sensitive mea-
surement techniques.
In addition to the CD56+,CD5- TN thymocyte popu-
lation, a significant percentage of TN thymocytes did not
express either the CD56 or CD5 antigens. At first we as-
sumed that these CD56 - ,CD5 - cells represented early T
cell thymic progenitors. A careful analysis of this population,
however, clearly indicated an antigenic phenotype strikingly
similar to the CD56+,CD5 - TN population, including
high surface density CD45 expression (a characteristic as-
sociated with mature lineage-committed cells (36) . Likewise,
the majority of these cells did not express the progenitor cell-
associated antigen, CD34 or the T cell-associated CD28 an-
tigen. Since the CD56`,CD5 - TN thymocyte population
showed no cytolytic activity and did not express the NK
cell-associated markers CD56 or CD16, we hypothesized that
these cellsmay represent a novel populationof NK cell-com-
mitted precursors. Indeed, the majority of clones established
from the CD56 - , CD5 - TN thymocytes were typical NK
cell clones acquiring high surface density CD56 and potent
cytolytic activity. Although we have characterized the
CD56- ,CD5' TN thymocyte population as containing NK
cell precursors, based on the ability of these cells to acquire
NK cell cytolytic function and antigenic phenotype, it is also
possible that these cellsmay represent a unique subset of NK
cells with unusual characteristics. We cannot exclude the pos-
sibility that this populationmay also contain other precursor
cells capable of differentiation in appropriate conditions. In-
deed, although the majority of the CD56 - ,CD5- TN
population did not express the progenitor cell-associated an-
tigen CD34, a small percentage of CD34+ T cell progen-
itors were consistently observed within this population that
could efficiently repopulate mFTOC and differentiate into
CD3+,CD4+,CD8+ T cells. Removal of these CD34+ cells
from CD56- ,CD5 - TN thymocytes had no effect on the
NK cell clonogenicpotential of this population. Our results,
in accordance with previous reports (12), clearly show that
the expression of CD34 on TN thymocytes is primarily re-
stricted to cells with T cell progenitor capabilities that do
not possess in vitro clonogenic capability in IL-2 (Table 1).
The growth and differentiation of T cell precursors requires
the presence of thymic stromal cells as previously reported
(12, 13, 37, 38, 39). Although NK cell and NK cell precursors
are TN thymocyte populations distinct from the majority
of T cell progenitors, there could exist a T/NK common pro-- No surface expression; + dim surface density; ' + bright surface density.
COMMITTED
T
THYMOCYTES
CD34-CD28'CD5'CD56+CD7++
CD45++CD45RA++CD1'CD16+
CD34'CD28'CD5-CD56 ++CD7++
CD45++CD45RA++CD1'CD16++
Figure 11.
￿
Hypothetical model of early human thymocytes develop-
ment: a view from uncommitted thymocytes to mature T and NK cells.
The hypothetical earliest thymic immigrant would express high density
(++) of surface antigens CD34 and CD7, and lack the expression (-)
ofTandNK cell-associated surfacemarkers (stageA). Undertheinfluence
of the thymic microenvironment, CD34'+ progenitors would differen-
tiate towardsacommittedTcell lineageby sequentially expressing CD28,
CD5, and CD1 andconcomitantly down regulating (++ =~ + =* -)
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genitor that is incapable of in vitro differentiation/matura-
tion using our culture conditions. Indeed, a previous study
(40) has shown that NK cells can be generated from bone
marrow-derived CD34+ cells when cultured on appropriate
stromal cell lines. Based on our observations and those of
others (12, 41, 42), we are now able to propose a hypothet-
ical model that may reflect the sequence of phenotypic and
functional changes leading to the differentiation ofNK cells
and T cells in the thymus (Fig. 11). According to our hypothet-
ical model, the most primitive hematopoietic progenitors to
enter the thymus would phenotypically resemble bone marrow
and fetal liver-derived hematopoietic progenitors (Fig. 11 A),
expressing high surface density CD34 and CD7 antigens, but
lacking the surface expression of CD5, CD28, CD56, and
other lineage-associated antigens. As differentiation under the
influence of the thymic microenvironmental proceeds, CD28
(Fig. 11 B) and CD5 (Fig. 11 C) expression is induced on
the high surface density CD34+ progenitor cells. Before the
expression ofCD5, we propose that the high surface density
CD34+ progenitor cells are uncommitted to the T cell lin-
eage and are thus capable of differentiation down the NK
cell pathway, resulting in the sequential loss of CD34 and
the gradual acquisition of CD56, CD16, and cytolytic func-
tion (Fig. 11, F-H). We speculate that the high surface den-
sity CD34-expressing progenitor cells that do not coexpress
CD5 are the most likely candidates for a common T/NK pro-
genitor population. Establishment of high efficiencyin vitro
cloning conditions that support the differentiation of NK
cells from thymic CD34+ population are required before we
the CD34 antigen(stages B, C, D, andF). The uncommitted progenitor
populations (stage A and/or B) could differentiate towards the NK lin-
eage, resulting in the down regulation of CD34 and progressive expres-
sion of NK cell associated markers (stages F, G, and M.
Table 1. Human Thymic TN Populations
NK cell-committed
CD34-
thymocytes T cell progenitor
CD34+
thymocytes
Characteristics CD56',CD5- CD56-,CD5 - CD56-,CD5 - CD56 -,CD5'
Antigenic CD1-,CD28-, CD1-,CD28-, CD1-,CD28+, CD1+,CD28+,
phenotype CD45RA'+,CD45 ++ CD45RA'+,CD45 ++ CD45RA+,CD45' CD45RA -,CD45'
Lytic function
(fresh) YES NO NO NO
NK cell clonogenic
potential YES YES NO NO
Thymic reconstitution
capability NO NO YES YEScan definitively identify the T/NK cell common progenitor.
Our model would also predict that T cell differentiation
would result in the progressive loss in CD34 expression on
CD28+,CD5+ TN thymocytes and the concomitant expres-
sion of CDl (Fig . 11 D) . This sequence of differentiation
events would thus signal irreversible commitment to theT
cell lineage.
In conclusion, although it is generallythought that human
TN thymorytes represent a relatively homogeneous popula-
tion ofT cell progenitors, our results indicate that they can
be subdivided into two major populations : CD34- cells that
proliferate and generate NK cells in cloning culture condi-
tions but are unable to differentiate toT cells in mFTOC;
and CD34+ T cell progenitors that are unable to differen-
tiate to NK cells in our culture conditions (Table 1) . The
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